SEC Filings
Cerus Says Germany Wants More Data On Its New LED Illuminator, And The FDA Decision Slips
Cerus can no longer build its old illuminator, and its quarterly report says the LED replacement faces extra data demands in Germany and the US.
Cerus (CERS) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Cerus can no longer build its old illuminator, and its quarterly report says the LED replacement faces extra data demands in Germany and the US.
Earnings
The blood-safety company kept its 2026 product revenue forecast, with U.S. fibrinogen sales up and a net loss of $0.6 million.